ArticleVeterinary research communications2025
Preventive effect of matrine on clostridium perfringens type A-induced diarrhoea in piglets.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clostridium perfringens (Cp) type A is one of the primary microorganisms responsible for bacterial diarrhoea in weaning piglets. Matrine, a tetracyclic quinolizidine alkaloid, exhibits diverse bioactive properties, including anti-inflammatory and neuroprotective effects. To better understand the anti-inflammatory mechanisms of Matrine on piglets infected with Cp type A (CpA). We investigated its preventive effects against diarrhoea over a 14-days period. Our results showed that 30 mg/kg of Matrine is non-toxic and does not harm the histological structure of organ tissues or alter the haematological indices of piglets. Matrine significantly reduced the abundance of CpA in faecal and intestines, as well as the content of toxin-α. The inflammatory response was mitigated following Matrine treatment, and physiological organ functions were restored, particularly through the repair of intestinal mucosal layer and sIgA level. Matrine also promoted a high abundance of beneficial intestinal microbiota, including Lactobacillus, Bacteroidota, Muribaculaceae, and Oscillospirales. This microbial composition inhibited the abundance of epithelial cells by Cp, thereby further reducing the diarrhoea rate and mortality in piglets. In conclusion, Matrine promotes the abundance of intestinal probiotics, inhibits the colonization of CpA, reduces the inflammatory response as well as restores intestinal tissue hismorphology. It will be used as a therapeutic agent diarrhea of piglets infected with CpA in the furture.
Indexed as
Identifiers
40856741What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.